Down‐modulation of programmed death 1 alters regulatory T cells and promotes experimental autoimmune encephalomyelitis
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
The regulatory role of programmed death 1 (PD‐1) was investigated in the development of experimental autoimmune encephalomyelitis (EAE), an animal model of multiple sclerosis. Typical EAE could be induced by immunization without pertussis toxin (PTX) in PD‐1‐null but not in wild‐type (WT) mice. However, both strains developed a similar EAE phenotype when immunized with PTX or by adoptive transfer of pathogenic T cells. In WT mice that did not develop EAE after immunization without PTX, the frequency of CD4+FoxP3+ Treg cells was boosted in the periphery but not in the thymus. This increase in Treg frequency was abrogated by PD‐1 deficiency or inclusion of PTX. In addition, PD‐1 expression was critical to in vitro conversion of naïve myelin‐specific CD4 T cells into Treg cells and was directly related to Treg suppressive activity. Finally, PD‐1 was markedly down‐modulated in the periphery of WT mice after administration of PTX. Therefore, down‐modulation of PD‐1 in Treg cells may abrogate Treg‐mediated immune suppression, permitting the activation of myelin‐reactive T cells and induction of EAE. © 2009 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction
Trautmann, L., Janbazian, L., Chomont, N., Said, E. A., Gimmig, S., Bessette, B., Boulassel, M.-R., Delwart, E., Sepulveda, H., Balderas, R. S., et al. (2006) · Nature Medicine · doi:10.1038/nm1482 · Cited by 1,565 · cited 1×
“…shown to up-regulate PD-1 expression on CD81 cells in individuals infected with chronic lymphocytic choriomeningitis, human immunodeficiency, and hepatitis C viruses (Barber et al., 2006; Day et al., 2006; Petrovas et al., 2006; Trautmann et al., 2006; Urbani et al., 2006; Okazaki and Honjo, 2007).”
BackgroundPD-1 and PD-1 ligands: from discovery to clinical application
Okazaki, T., & Honjo, T. (2007) · International Immunology · doi:10.1093/intimm/dxm057 · Cited by 1,310 · cited 4×
“On the other hand, a variety of microorganisms that cause chronic infections were shown to up-regulate PD-1 expression on CD8(1) cells in individuals infected with chronic lymphocytic choriomeningitis, human immunodeficiency, and hepatitis C viruses (Barber et al., 2006; Day et al., 2006; Petrovas et al., 2006; Trautm…”
BackgroundInfluentialPD-1 is a regulator of virus-specific CD8+ T cell survival in HIV infection
Petrovas, C., Casazza, J. P., Brenchley, J. M., Price, D. A., Gostick, E., Adams, W. C., Precopio, M. L., Schacker, T., Roederer, M., Douek, D. C., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20061496 · Cited by 889 · cited 2×
“On the other hand, a variety of microorganisms that cause chronic infections were shown to up-regulate PD-1 expression on CD8(1) cells in individuals infected with chronic lymphocytic choriomeningitis, human immunodeficiency, and hepatitis C viruses (Barber et al., 2006; Day et al., 2006; Petrovas et al., 2006; Trautm…”
BackgroundBettelli, E., Baeten, D., Jäger, A., Sobel, R. A., & Kuchroo, V. K. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28334 · Cited by 336 · cited 2×
“, 2000), kept in nonsterile environment (Goverman et al., 1993; Bettelli et al., 2006), or challenged with immunization or microbial agents.”
Background
Cited by
The PD‐1 pathway in tolerance and autoimmunity
Francisco, L. M., Sage, P. T., & Sharpe, A. H. (2010) · Immunological Reviews · doi:10.1111/j.1600-065x.2010.00923.x · Cited by 2,300
The receptor PD-1 controls follicular regulatory T cells in the lymph nodes and blood
Sage, P. T., Francisco, L. M., Carman, C. V., & Sharpe, A. H. (2013) · Nature Immunology · doi:10.1038/ni.2496 · Cited by 467
Role of the PD-1 pathway in the immune response
Riella, L. V., Paterson, A. M., Sharpe, A. H., & Chandraker, A. (2012) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2012.04224.x · Cited by 444
TGFβ1-Mediated SMAD3 Enhances PD-1 Expression on Antigen-Specific T Cells in Cancer
Park, B. V., Freeman, Z. T., Ghasemzadeh, A., Chattergoon, M. A., Rutebemberwa, A., Steigner, J., Winter, M. E., Huynh, T. V., Sebald, S. M., Lee, S.-J., et al. (2016) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-1347 · Cited by 287
Recent insights into the role of the PD-1/PD-L1 pathway in immunological tolerance and autoimmunity
Gianchecchi, E., Delfino, D. V., & Fierabracci, A. (2013) · Autoimmunity Reviews · doi:10.1016/j.autrev.2013.05.003 · Cited by 270
Metadata
- Authors
- Wang, C., Li, Y., Proctor, T. M., Vandenbark, A. A., & Offner, H.
- Venue
- Journal of Neuroscience Research
- Publisher
- Wiley
- Published
- 2009-07-29
- Volume
- 88
- Issue
- 1
- Pages
- 7-15
- ISSN
- 0360-4012 (ISSN-L)
- 1097-4547
- OpenAlex
- W2091805754
- Cited by
- 44
- References
- 4
- FWCI
- 1.40
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.